Effect of tofacitinib on clinical and laboratory findings in severe and resistant patients with COVID-19.
Almasi S, Rashidi A, Kachuee MA, Shirazi BM, Izadi S, Ghaffarpour S, Azimi M, Naghizadeh MM, Makiani MJ, Ranjbar M, Goudarzi M, Rahimian N, Ghazanfari T.
Almasi S, et al. Among authors: shirazi bm.
Int Immunopharmacol. 2023 Sep;122:110565. doi: 10.1016/j.intimp.2023.110565. Epub 2023 Jun 30.
Int Immunopharmacol. 2023.
PMID: 37454635